KIF18A Antibodies

Santa Cruz Biotechnology delivers a wide array of KIF18A monoclonal antibodies for various research applications. KIF18A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIF18A, a member of the kinesin superfamily, plays a crucial role in the regulation of mitotic spindle dynamics and chromosome alignment during cell division. Its proper function is essential for maintaining genomic stability, and alterations in KIF18A expression have been implicated in various cancers. Understanding KIF18A's role in cellular processes can provide insights into potential therapeutic targets for cancer treatment. Researchers worldwide utilize KIF18A monoclonal antibodies to investigate cell division mechanisms and their relationship to disease development. Advanced research with KIF18A monoclonal antibodies continues to reveal new aspects of chromosome segregation and cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing cancer research and therapeutic development through precise and reliable detection methods.